Differentiate leak, overfiltration, obstruction, scarring, aqueous misdirection, choroidal complications and infection; plan individual aftercare and urgent access.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Read pressure, chamber and bleb together
Aftercare is part of surgery: assess IOP, vision, anterior-chamber depth, inflammation, wounds/bleb, implant position and cornea. Early low pressure requires identifying leak, overfiltration or other cause; high pressure requires identifying retained viscoelastic, hyphema, steroid response, obstruction or scarring. A shallow chamber, infection or vision deterioration needs prompt specialist assessment. Bleb massage, suture adjustment, needling and 5-FU/MMC are selected interventions, not routine instructions for every patient. Risks include hypotony maculopathy, choroidal complications, tube exposure and late bleb infection. Follow-up remains individualized and long term. 1 2 3 4
The original preference for early high pressure over low pressure is a teaching warning about hypotony, not a policy to accept untreated hypertension. Assess the optic nerve, chamber, macula and wound: numerical hypotony alone differs from vision-threatening hypotony maculopathy, while advanced glaucoma can tolerate little additional high-pressure exposure. 6 7
02Use the actual tissue and healing risk
High myopia, thin sclera and tissue disorders such as Marfan may require modified flap geometry and flow control. The original larger flap/3–4 rather than 2 sutures is an example, not compulsory for every myopic eye. Small hyperopic eyes and a shallow chamber raise concern for postoperative crowding/misdirection but do not predict it with certainty. 6 7
Young age, previous conjunctival surgery, chronic topical exposure, diabetes and inflammation can affect healing. Population associations with African or Asian ancestry do not diagnose individual fibrosis or make MMC unavoidable. Examine conjunctiva and tissue integrity, control inflammation and plan surveillance rather than applying one risk label to every patient. 6 7
03Relate bleb appearance to flow and obstruction
A guarded sclerostomy beneath the scleral flap drains to the subconjunctival space. A peaked or pear-shaped pupil towards it can suggest iris incarceration, but is not pathognomonic: examine the chamber, gonioscopic internal opening where appropriate, tube/flap and other causes of pressure rise before deciding on release. 6 7
A diffuse functioning bleb is generally preferable to a focal thin cyst, but avascularity alone is not an ideal-health sign: thin avascular or leaking blebs have infection risk. Marked vascularity (“angry bleb”) may accompany active healing; a tense encapsulated Tenon cyst may restrict flow and raise pressure. Appearance alone does not prescribe massage, needling or antimetabolite treatment. 6 7
04Find the cause of low pressure and chamber shallowing
Seidel testing helps identify external aqueous leakage; a negative result does not establish overfiltration or exclude every intermittent leak. Bleb height alone does not reliably separate the two. Assess wounds, chamber depth, inflammation, choroid and macula before selecting observation, protective measures or revision. 6 7
Resuturing can reduce excessive flow; selected contact-lens protection or conjunctival revision can address a leak. Reducing steroids to encourage healing is not appropriate for every low-pressure eye: inflammation itself can suppress aqueous production. Select the intervention with the surgeon according to cause and threat rather than a single numeric IOP. 6 7
B-scan can define choroidal elevations and associated haemorrhage/retinal findings when visibility is limited. Selected cycloplegia, control of inflammation and repair of the pressure/fluid cause may suffice for uncomplicated effusion. Chamber reformation with cohesive viscoelastic (original Healon) and drainage are selected interventions for the actual anatomy and course, not compulsory sequential first-line steps for every choroidal detachment. 6 7
05Separate obstruction, misdirection and haemorrhage
High pressure with a shallow chamber despite a patent iridectomy raises suspicion of aqueous misdirection, but first exclude other anterior/posterior pushing causes. Cycloplegia and aqueous suppression, selected YAG capsulotomy/hyaloidotomy or vitrectomy depend on lens status and anatomy. “Single chamber” describes a communication goal, not one mandatory operation or freedom from recurrence. 6 7
Sudden pain and visual decline with choroidal elevation after surgery require urgent assessment for suprachoroidal haemorrhage. Age, hypertension, anticoagulation and straining may inform risk, not prove the diagnosis. Stabilise the eye and treat pain/pressure according to the actual presentation; do not apply automatic pressure lowering to every hypotonic bleeding eye. Drainage timing depends on anatomy, apposition, pressure, pain, retinal involvement and evolution; the original “only kissing choroids or lens–cornea contact” rule is too restrictive. 6 7
06Treat scarring and infection as different problems
Subconjunctival scarring is an important filtration-failure mechanism. Needling with selected MMC/5-FU or surgical revision may restore flow, but confirm obstruction and exclude leak/infection first. Timing, substance and route require specialist planning; one red bleb is not automatically a needling indication. 6 7
Blebitis is infection centred on the bleb; vitreous/intraocular involvement raises concern for endophthalmitis. Do not wait for every classic sign or let swabbing delay urgent treatment. Intensive topical treatment for selected blebitis differs from intravitreal antibiotics and possible surgery for endophthalmitis; original vancomycin/ceftazidime names do not define a preparation recipe. 6 7
07Check tube flow, coverage and corneal distance
Non-valved Baerveldt flow commonly needs temporary ligation and/or intraluminal restriction during capsule formation. Original 6-0 Vicryl and approximately 6 weeks are examples, not fixed dissolution or safe rip-cord-removal dates. A rip-cord and an external ligature are different flow-control components; assess pressure and anatomy before intervention. 6 7
A hypertensive phase may occur during healing; original 3 weeks–3 months is a teaching window, not the only possible timing. Exclude obstruction, ligature effects, inflammation and steroid response rather than labelling every rise encapsulation. Medication and procedural management are individual. 6 7
Implant exposure carries infection risk and requires prompt specialist review; selected patch coverage, conjunctival repair or repositioning depends on the defect and device. A tube close to the corneal endothelium can cause progressive endothelial loss; consider shortening/repositioning, including a suitable sulcus route in the appropriate lens anatomy. Neither a patch nor absence of visible touch eliminates every long-term risk. 6 7
08Individualise antifibrotics, drops and lifelong access
Original MMC 0.2 mg/ml for 2–3 minutes is not a universal DOG/BVA protocol. Select concentration, area, application and exposure from the actual operation, tissue and product/local rules; antifibrotics can increase hypotony, thin blebs, leaks and infection. No preparation or intraocular-use instruction follows from the historical number. 6 7
Daily checks in week 1, weekly checks until 4–6 weeks and topical antibiotics 1–4 weeks/four times daily are original schedules, not compulsory for every procedure or patient. Give a written individual review/drop plan, including separate steroid taper and antibiotic duration; review sooner for abnormal findings. 6 7
The operation lowers pressure to protect remaining sight; drops or further procedures may still be needed. Attend scheduled checks and follow the individually prescribed drops and restrictions on rubbing, lifting and water exposure; duration is operation-specific. Severe pain, increasing redness, discharge or sudden visual loss requires immediate contact with the surgical team/emergency eye service. Late infection can occur months or years after bleb surgery. Educational information does not replace examination or individualized treatment. 5
| Problem | Finding/mechanism | Selected assessment/response | Original boundary |
|---|---|---|---|
| Hypotony | Leak/overfiltration or other cause | Wound/Seidel/chamber/macula/choroid; selected repair | Cohesive viscoelastic is not mandatory for every effusion |
| Aqueous misdirection | Uniform shallow chamber despite patent iridectomy | Exclude other causes; cycloplegia/selected communication | Single-chamber goal is not a universal operation |
| Fibrosis | Vascular/encapsulated bleb and rising pressure | Confirm cause; selected needling/revision | MMC 0.2 mg/ml/2–3 min is not a universal rule |
| Infection | Blebitis versus intraocular involvement | Urgent specialist antibiotics/sampling/selected surgery | Lifelong warning education; no fixed acuity shortcut |
| Baerveldt tube | Early flow restriction and later healing | Ligature/rip-cord/pressure review individualized | Original 6 weeks is not a guaranteed opening date |
| Myopic tissue risk | Thin sclera/healing context | Plan flap/sutures/flow and close follow-up | Original 3–4 sutures not obligatory in every eye |
| Internal opening | Peaked/pear-shaped pupil can suggest iris incarceration | Inspect mechanism before selected release | Not pathognomonic from pupil shape alone |
What are the main learning points?
Differentiate leak, overfiltration, obstruction, scarring, aqueous misdirection, choroidal complications and infection; plan individual aftercare and urgent access.
When is assessment urgent?
Seek immediate ophthalmic assessment for sudden visual loss, severe/increasing pain, redness or discharge, even years after filtering surgery.
References and access status
- 1EGS 6 (2025), professional guideline; full text inspected, pp.22–24,163–164,192–202.
Historical 187-glaucoma-surgery appraisal reused; not new full-source access. Historical 004 source appraisal of 1 October 2026 reused; scope is stated in the title and source dossier, not fresh full-source access.
- 2PTVT 5-year RCT: Baerveldt 350 versus trabeculectomy+MMC, no previous incisional ocular surgery.
Historical 187-glaucoma-surgery appraisal reused; not new full-source access. Historical 004 source appraisal of 1 October 2026 reused; scope is stated in the title and source dossier, not fresh full-source access.
- 3MicroShunt versus trabeculectomy, randomized noninferiority trial,2 years.
Historical 187-glaucoma-surgery appraisal reused; not new full-source access. Historical 004 source appraisal of 1 October 2026 reused; scope is stated in the title and source dossier, not fresh full-source access.
- 4XEN 45 GPS POAG subgroup, randomized study 12 months,2025.
Historical 187-glaucoma-surgery appraisal reused; not new full-source access. Historical 004 source appraisal of 1 October 2026 reused; scope is stated in the title and source dossier, not fresh full-source access.
- 5Immutable original export; MIGS/MIBS original; own table/video preserved
Historical 187-glaucoma-surgery appraisal reused; not new full-source access. Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 6Immutable original export; own complication lecture; SamerAwad/Plowman attribution unverified
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 7EGS 6 selected surgery and antifibrotic precautions pp 194–196,203–204
Selected locally cached narrative read 17 November 2026: hypotony/late infection, GDD exposure/cornea and flow restriction, individual antifibrotic precautions; not a complete complication manual/IFU or new whole-guideline appraisal.
Original lecture link
For patients
Glaucoma surgery aims to protect remaining sight. Healing and drainage need monitoring; complications may require changes in drops or further procedures.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Seek immediate ophthalmic assessment for sudden visual loss, severe/increasing pain, redness or discharge, even years after filtering surgery.
Seek immediate ophthalmic assessment for sudden visual loss, severe/increasing pain, redness or discharge, even years after filtering surgery.